Kim Sugino

Title(s)Clinical Nurse, Women and Infants Services
SchoolVc-health Sciences-health
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves' disease. Endocr J. 2024 Oct 23. Suzuki N, Yoshimura Noh J, Kozaki A, Watanabe N, Yoshihara A, Fukushita M, Matsumoto M, Imai H, Hiruma S, Ichikawa M, Koshibu M, Sankoda A, Hirose R, Inoue T, Sugino K, Ito K. PMID: 39443096.
      View in: PubMed   Mentions:
    2. Management of follicular thyroid carcinoma. Eur Thyroid J. 2024 Oct 01; 13(5). Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, Saito A, Ito K. PMID: 39419099.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Exacerbation of Thyroid Eye Disease and Dysthyroid Optic Neuropathy During Pregnancy: A Case Report. Intern Med. 2024 Sep 11. Koshibu M, Watanabe N, Suzuki N, Takahashi Y, Onda H, Kozaki A, Hiruma S, Ichikawa M, Hirose R, Imai H, Sankoda A, Fukushita M, Yoshihara A, Matsumoto M, Yoshimura Noh J, Sugino K, Ito K. PMID: 39261069.
      View in: PubMed   Mentions:    Fields:    
    4. Active surveillance vs. surgery in low-risk papillary thyroid microcarcinoma patients and the risk of loss to follow-up. Cancer Med. 2024 Aug; 13(16):e70123. Saito Y, Matsuzu K, Takami H, Matsui A, Kuga Y, Ohara R, Yoshioka K, Masaki C, Akaishi J, Hames KY, Okamura R, Tomoda C, Suzuki A, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 39194351; PMCID: PMC11350832.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Subacute thyroiditis during pregnancy: clinical characteristics of seven cases. Eur Thyroid J. 2024 Aug 01. Imai H, Watanabe N, Hirose R, Koshibu M, Ichikawa M, Sankoda A, Hiruma S, Suzuki N, Matsumoto M, Fukushita M, Yoshihara A, Yoshimura Noh J, Sugino K, Ito K. PMID: 39213615.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil. Endocr J. 2024 Jul 12; 71(7):695-703. Yoshimura Noh J, Inoue K, Suzuki N, Yoshihara A, Fukushita M, Matsumoto M, Imai H, Hiruma S, Ichikawa M, Koshibu M, Sankoda A, Hirose R, Watanabe N, Sugino K, Ito K. PMID: 38710619.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Role of the Degree of Vascular Invasion in Predicting Prognosis of Follicular Thyroid Carcinoma. J Clin Endocrinol Metab. 2024 Apr 19; 109(5):1291-1300. Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, Rino Y, Saito A, Ito K. PMID: 38006314.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer. Thyroid. 2024 May; 34(5):566-574. Tahara M, Takami H, Ito Y, Okamoto T, Sugitani I, Sugino K, Takahashi S, Takeyama H, Tsutsui H, Hara H, Mitsuma A, Yamashita H, Ohashi Y, Imai T. PMID: 38629757.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Determination of Capillary Blood TSH and Free Thyroxine Levels Using Digital Immunoassay. J Endocr Soc. 2024 Feb 19; 8(4):bvae030. Suzuki N, Takeuchi M, Miyazaki N, Tanaka K, Utsunomiya S, Arai Y, Yoshimura T, Sugino K, Ito K, Noh JY. PMID: 38410786; PMCID: PMC10895209.
      View in: PubMed   Mentions:
    10. An Evaluation of the Efficacy of Machine Learning in Predicting Thyrotoxicosis and Hypothyroidism: A Comparative Assessment of Biochemical Test Parameters Used in Different Health Checkups. Intern Med. 2024 Aug 15; 63(16):2259-2268. Yoshimura Noh J, Yoshihara A, Hiruma S, Ichikawa M, Hirose R, Koshibu M, Imai H, Sankoda A, Suzuki N, Fukushita M, Matsumoto M, Watanabe N, Sugino K, Ito K. PMID: 38171877.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. The importance of early-stage blood pressure control in thyroid cancer patients treated with lenvatinib from the perspective of dose intensity. Support Care Cancer. 2023 Nov 29; 31(12):729. Masaki C, Shioya J, Sugino K, Terasawa Y, Yokotsuka S, Nakata M, Kitagawa W, Ito K. PMID: 38017341.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive score. Endocr J. 2023 Nov 28; 70(11):1087-1096. Watanabe N, Yoshimura Noh J, Kozaki A, Yoshimura R, Yoshihara A, Suzuki N, Matsumoto M, Fukushita M, Kinoshita A, Aida A, Imai H, Hiruma S, Inoue T, Inoue K, Sugino K, Ito K. PMID: 37743517.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Clinical classification of recurrent laryngeal nerve palsy. Gland Surg. 2023 Sep 25; 12(9):1203-1208. Tomoda C, Yoshioka K, Saito Y, Masaki C, Akaishi J, Hames KY, Okamura R, Suzuki A, Matsuzu K, Kitagawa W, Sugino K, Ito K. PMID: 37842531; PMCID: PMC10570980.
      View in: PubMed   Mentions:
    14. New Insights on the Importance of the Extent of Vascular Invasion in Widely Invasive Follicular Thyroid Carcinoma. World J Surg. 2023 Nov; 47(11):2767-2775. Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, Rino Y, Ito K. PMID: 37516689.
      View in: PubMed   Mentions: 1     Fields:    
    15. Establishment of reference intervals for fT3, fT4, and TSH levels in Japanese children and adolescents. Endocr J. 2023 Aug 28; 70(8):815-823. Mitsumatsu T, Yoshimura Noh J, Iwaku K, Yoshihara A, Watanabe N, Aida A, Yoshimura R, Mikura K, Kinoshita A, Suzuki A, Suzuki N, Fukushita M, Matsumoto M, Sugino K, Ito K. PMID: 37286518.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Adult Thyroid Outcomes of Congenital Hypothyroidism. Thyroid. 2023 05; 33(5):556-565. Sugisawa C, Narumi S, Tanase-Nakao K, Hoshiyama A, Suzuki N, Ohye H, Fukushita M, Matsumoto M, Yoshihara A, Watanabe N, Sugino K, Hishinuma A, Noh JY, Katoh R, Taniyama M, Ito K. PMID: 36792927.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease. Endocr J. 2023 May 29; 70(5):541-549. Mikura K, Yoshimura Noh J, Watanabe N, Aida A, Yoshimura R, Kinoshita A, Suzuki A, Suzuki N, Fukushita M, Matsumoto M, Yoshihara A, Sugino K, Ito K. PMID: 36843112.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification. Cancers (Basel). 2023 Feb 24; 15(5). Saito Y, Watanabe N, Suzuki N, Saito N, Narimatsu H, Takami H, Kameyama K, Yoshioka K, Masaki C, Akaishi J, Hames KY, Matsumoto M, Fukushita M, Yoshihara A, Okamura R, Tomoda C, Suzuki A, Matsuzu K, Kitagawa W, Nagahama M, Noh JY, Sugino K, Ito K. PMID: 36900242; PMCID: PMC10000773.
      View in: PubMed   Mentions: 1  
    19. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery. Thyroid. 2023 03; 33(3):373-379. Yoshihara A, Noh JY, Inoue K, Watanabe N, Fukushita M, Matsumoto M, Suzuki N, Suzuki A, Kinoshita A, Yoshimura R, Aida A, Imai H, Hiruma S, Sugino K, Ito K. PMID: 36680759.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Evaluation of factors predicting postoperative recurrence and metastasis of parathyroid cancer: a single-center study. World J Surg Oncol. 2023 Feb 03; 21(1):32. Ohkuwa K, Katoh R, Sugino K, Nagahama M, Kitagawa W, Matsuzu K, Fukunari N, Ito K. PMID: 36737774; PMCID: PMC9896802.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study. Drugs Real World Outcomes. 2023 Mar; 10(1):145-158. Masaki C, Sugino K, Tanizawa Y, Nakamura K, Okada Y, Cai Z, Okamoto T. PMID: 36527599; PMCID: PMC9943803.
      View in: PubMed   Mentions: 1  
    22. Correction: Encapsulated Angioinvasive Follicular Thyroid Carcinoma: Prognostic Impact of the Extent of Vascular Invasion. Ann Surg Oncol. 2022 Dec; 29(13):8213. Yamazaki H, Katoh R, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames KY, Tomoda C, Suzuki A, Ohkuwa K, Kitagawa W, Nagahama M, Rino Y, Ito K. PMID: 36138288.
      View in: PubMed   Mentions: 1     Fields:    
    23. Impact of Age on Prognosis in Papillary Thyroid Carcinoma: How Should Age be Incorporated into the Treatment Strategy? World J Surg. 2023 03; 47(3):674-681. Sugino K, Matsuzu K, Nagahama M, Kitagawa W, Suzuki A, Tomoda C, Hames KY, Akaishi J, Masaki C, Yoshioka K, Saito Y, Ito K. PMID: 36445452.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid disease. Endocr J. 2023 Feb 28; 70(2):141-148. Hiruma M, Watanabe N, Mitsumatsu T, Suzuki N, Fukushita M, Matsumoto M, Yoshihara A, Yoshimura Noh J, Sugino K, Ito K. PMID: 36198616.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. The Mediation Role of Thyrotropin Receptor Antibody in the Relationship Between Age and Severity of Hyperthyroidism in Graves' Disease. Thyroid. 2022 Oct; 32(10):1243-1248. Suzuki N, Inoue K, Yoshimura R, Kinoshita A, Suzuki A, Fukushita M, Matsumoto M, Yoshihara A, Watanabe N, Noh JY, Katoh R, Sugino K, Ito K. PMID: 36074931.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Impact of Local Control on Clinical Course in Stage IVC Anaplastic Thyroid Carcinoma. World J Surg. 2022 12; 46(12):3034-3042. Yamazaki H, Sugino K, Katoh R, Masudo K, Matsuzu K, Kitagawa W, Nagahama M, Rino Y, Ito K. PMID: 36127501.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma. Cancer Med. 2023 02; 12(3):3027-3035. Yamazaki H, Sugino K, Katoh R, Matsuzu K, Masaki C, Akaishi J, Hames KY, Tomoda C, Suzuki A, Ohkuwa K, Kitagawa W, Nagahama M, Rino Y, Ito K. PMID: 36052510; PMCID: PMC9939216.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE). Eur J Cancer. 2022 09; 173:210-218. Higashiyama T, Sugino K, Hara H, Ito KI, Nakashima N, Onoda N, Tori M, Katoh H, Kiyota N, Ota I, Suganuma N, Hibi Y, Nemoto T, Takahashi S, Yane K, Ioji T, Kojima S, Kaneda H, Sugitani I, Tahara M. PMID: 35932627.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    29. Preoperative inflammatory markers for predicting parathyroid carcinoma. Endocr Connect. 2022 Jul 01; 11(7). Ohkuwa K, Sugino K, Katoh R, Nagahama M, Kitagawa W, Matsuzu K, Suzuki A, Tomoda C, Hames K, Akaishi J, Masaki C, Yoshioka K, Ito K. PMID: 35700222; PMCID: PMC9346317.
      View in: PubMed   Mentions: 2  
    30. Successful dose escalation of lenvatinib for thyroid cancer after disease progression. Endocrine. 2022 10; 78(1):77-84. Masaki C, Sugino K, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 35737285.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Associations Between Plasma Concentrations of Lenvatinib and Angiopoietin and Clinical Responses to Lenvatinib Therapy in Japanese Patients With Thyroid Cancer. Cancer Diagn Progn. 2022 May-Jun; 2(3):336-344. Kumagai M, Nagahama M, Akamine Y, Ozeki T, Suzuki A, Sugino K, Ito K, Miura M. PMID: 35530647; PMCID: PMC9066539.
      View in: PubMed   Mentions: 1  
    32. The Relationship Between Primary Thyroid Lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease. Thyroid. 2022 05; 32(5):552-559. Suzuki N, Watanabe N, Noh JY, Yoshimura R, Mikura K, Kinoshita A, Suzuki A, Mitsumatsu T, Fukushita M, Matsumoto M, Yoshihara A, Katoh R, Sugino K, Ito K. PMID: 35229626.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Predictors of maximum efficacy of lenvatinib for real-world patients with differentiated thyroid carcinoma. Surg Today. 2022 Nov; 52(11):1660-1669. Masaki C, Sugino K, Saito N, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 35411497.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profile. Endocr J. 2022 Sep 28; 69(9):1091-1100. Yoshihara A, Yoshimura Noh J, Inoue K, Taguchi J, Hata K, Aizawa T, Taira Arai Y, Watanabe N, Fukushita M, Matsumoto M, Suzuki N, Hoshiyama A, Suzuki A, Mitsumatsu T, Kinoshita A, Mikura K, Yoshimura R, Sugino K, Ito K. PMID: 35387949.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Encapsulated Angioinvasive Follicular Thyroid Carcinoma: Prognostic Impact of the Extent of Vascular Invasion. Ann Surg Oncol. 2022 Feb 15. Yamazaki H, Katoh R, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames KY, Tomoda C, Suzuki A, Ohkuwa K, Kitagawa W, Nagahama M, Rino Y, Ito K. PMID: 35169976.
      View in: PubMed   Mentions: 1     Fields:    
    36. ASO Author Reflections: Encapsulated Angio-Invasive Follicular Thyroid Carcinoma: Prognostic Impact of the Extent of Vascular Invasion. Ann Surg Oncol. 2022 Feb 09. Yamazaki H, Katoh R, Sugino K, Matsuzu K, Kitagawa W, Nagahama M, Rino Y, Ito K. PMID: 35138494.
      View in: PubMed   Mentions:    Fields:    
    37. Clinical course and outcome of differentiated thyroid cancer patients with pregnancy after diagnosis of distant metastasis. Endocrine. 2022 04; 76(1):78-84. Yamazaki H, Sugino K, Noh JY, Katoh R, Matsuzu K, Masaki C, Akaishi J, Hames KY, Tomoda C, Suzuki A, Ohkuwa K, Kitagawa W, Nagahama M, Rino Y, Ito K. PMID: 35064544.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Spatially resolved immune microenvironmental profiling for follicular thyroid carcinoma with minimal capsular invasion. Mod Pathol. 2022 06; 35(6):721-727. Saburi S, Tsujikawa T, Miyagawa-Hayashino A, Mitsuda J, Yoshimura K, Kimura A, Morimoto H, Ohmura G, Arai A, Ogi H, Konishi E, Itoh K, Sugino K, Hirano S. PMID: 34952946.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    39. Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 Pandemic. J Endocr Soc. 2022 Jan 01; 6(1):bvab181. Inoue K, Noh JY, Yoshihara A, Watanabe N, Matsumoto M, Fukushita M, Suzuki N, Hoshiyama A, Mitsumatsu T, Suzuki A, Kinoshita A, Mikura K, Yoshimura R, Sugino K, Ito K. PMID: 34934884; PMCID: PMC8677518.
      View in: PubMed   Mentions: 4  
    40. Cutoff Age Between Pediatric and Adult Thyroid Differentiated Cancer: Is 18 Years Old Appropriate? Thyroid. 2022 02; 32(2):145-152. Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Matsuzu K, Suzuki A, Tomoda C, Hames KY, Akaishi J, Masaki C, Yoshioka K, Ito K. PMID: 34549602.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients. BMC Cancer. 2021 Aug 05; 21(1):894. Masaki C, Sugino K, Kobayashi S, Hosoi Y, Ono R, Yamazaki H, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 34353305; PMCID: PMC8340367.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Risk stratification in differentiated thyroid cancer with RAI-avid lung metastases. Endocr Connect. 2021 Jul 26; 10(8):825-833. Ohkuwa K, Sugino K, Nagahama M, Kitagawa W, Matsuzu K, Suzuki A, Tomoda C, Hames K, Akaishi J, Masaki C, Ito K. PMID: 34223823; PMCID: PMC8346177.
      View in: PubMed   Mentions: 7  
    43. Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease? Thyroid. 2021 09; 31(9):1409-1415. Suzuki N, Noh JY, Yoshimura R, Mikura K, Kinoshita A, Suzuki A, Mitsumatsu T, Hoshiyama A, Fukushita M, Matsumoto M, Yoshihara A, Watanabe N, Sugino K, Ito K. PMID: 33882721.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. A case of macro-TSH consisting of IgA-bound TSH. Endocr J. 2021 Oct 28; 68(10):1241-1246. Fukushita M, Watanabe N, Yoshimura Noh J, Yoshihara A, Matsumoto M, Suzuki N, Yoshimura R, Sugino K, Ito K. PMID: 34039782.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. The Time Series Behavior of Neutrophil-to-Lymphocyte Ratio in Thyroid Cancer Patients on Tyrosine Kinase Inhibitor Therapy. ORL J Otorhinolaryngol Relat Spec. 2021; 83(5):347-353. Tomoda C, Sugino K, Kitagawa W, Nagahama M, Ito K. PMID: 33735904.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    46. Clinical Course of Euthyroid Subjects With Positive TSH Receptor Antibody: How Often Does Graves' Disease Develop? J Endocr Soc. 2021 Jun 01; 5(6):bvab042. Suzuki N, Kawaguchi A, Yoshimura Noh J, Yoshimura R, Mikura K, Kinoshita A, Suzuki A, Mitsumatsu T, Hoshiyama A, Fukushita M, Matsumoto M, Yoshihara A, Watanabe N, Sugino K, Ito K. PMID: 34017933; PMCID: PMC8122366.
      View in: PubMed   Mentions: 3  
    47. Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. J Endocr Soc. 2021 Mar 01; 5(3):bvaa204. Yoshihara A, Noh JY, Watanabe N, Fukushita M, Matsumoto M, Suzuki N, Hoshiyama A, Suzuki A, Mitsumatsu T, Kinoshita A, Mikura K, Yoshimura R, Sugino K, Ito K. PMID: 33506163; PMCID: PMC7814387.
      View in: PubMed   Mentions:
    48. Clinical management of low-risk papillary thyroid microcarcinoma. Minerva Endocrinol (Torino). 2021 12; 46(4):413-427. Masaki C, Sugino K, Ito K. PMID: 33435642.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Outcomes for Minimally Invasive Follicular Thyroid Carcinoma in Relation to the Change in Age Stratification in the AJCC 8th Edition. Ann Surg Oncol. 2021 Jul; 28(7):3576-3583. Yamazaki H, Sugino K, Katoh R, Matsuzu K, Masaki C, Akaishi J, Yamada Hames K, Tomoda C, Suzuki A, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K. PMID: 33237449.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. ASO Author Reflections: Outcomes for Minimally Invasive Follicular Thyroid Carcinoma in AJCC 8th Edition. Ann Surg Oncol. 2021 Jul; 28(7):3584. Yamazaki H, Sugino K, Katoh R, Matsuzu K, Masuda M, Ito K. PMID: 33225393.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Distant Metastasis in Pediatric and Adolescent Differentiated Thyroid Cancer: Clinical Outcomes and Risk Factor Analyses. J Clin Endocrinol Metab. 2020 11 01; 105(11). Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Uruno T, Matsuzu K, Suzuki A, Tomoda C, Hames KY, Akaishi J, Masaki C, Ito K. PMID: 32813019.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    52. Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature. Endocr J. 2021 Feb 28; 68(2):145-151. Hiruma M, Sasano Y, Watanabe N, Yoshihara A, Ishii S, Yaguchi Y, Yoshimura Noh J, Sugino K, Ito K. PMID: 32999132.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease. Eur Thyroid J. 2021 Nov; 10(6):468-475. Watanabe N, Yoshimura Noh J, Hattori N, Iwaku K, Suzuki N, Yoshihara A, Ohye H, Suzuki M, Matsumoto M, Endo K, Kunii Y, Takagi G, Sugino K, Ito K. PMID: 34956919; PMCID: PMC8647084.
      View in: PubMed   Mentions:    Fields:    
    54. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease. Endocr J. 2020 Oct 28; 67(10):1019-1022. Suzuki N, Yoshihara A, Yoshimura Noh J, Kinoshita K, Ohnishi J, Saito M, Sugino K, Ito K. PMID: 32522908.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Clinical outcomes and risk stratification for papillary thyroid carcinoma presenting with distant metastasis before the era of tyrosine kinase inhibitors. Endocr J. 2020 Aug 28; 67(8):869-876. Matsuzu K, Sugino K, Masudo K, Mori K, Ono R, Yamazaki H, Masaki C, Akaishi J, Kiyomi Yamada H, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Takami H, Ito K. PMID: 32350192.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. Urinalysis by combination of the dipstick test and urine protein-creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer. Int J Clin Oncol. 2020 Jul; 25(7):1278-1284. Masaki C, Sugino K, Kobayashi S, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 32347432.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    57. Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma. Endocrine. 2020 10; 70(1):115-122. Yamazaki H, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames K, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K. PMID: 32307657.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    58. Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease. Endocr J. 2020 Jun 29; 67(6):631-638. Suzuki N, Yoshimura Noh J, Sugisawa C, Hoshiyama A, Hiruma M, Kawaguchi A, Morisaki M, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Yoshihara A, Watanabe N, Sugino K, Ito K. PMID: 32188795.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    59. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk? Thyroid. 2020 04; 30(4):548-556. Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Uruno T, Matsuzu K, Suzuki A, Tomoda C, Hames KY, Akaishi J, Masaki C, Ito K. PMID: 31910105.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    60. Rapid disease progression after discontinuation of lenvatinib in thyroid cancer. Medicine (Baltimore). 2020 Mar; 99(11):e19408. Yamazaki H, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames K, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K. PMID: 32176066; PMCID: PMC7220477.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    61. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy. Thyroid. 2020 03; 30(3):451-456. Yoshihara A, Noh JY, Watanabe N, Kunii Y, Suzuki M, Matsumoto M, Suzuki N, Hiruma M, Morisaki M, Kawaguchi A, Sugino K, Ito K. PMID: 31928169.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. Efficacy and Limitations of Lenvatinib Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer: Real-World Experiences. Thyroid. 2020 02; 30(2):214-221. Masaki C, Sugino K, Saito N, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 31854270.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    63. Sarcopenia is a prognostic factor for TKIs in metastatic thyroid carcinomas. Endocrine. 2020 04; 68(1):132-137. Yamazaki H, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames K, Tomoda C, Suzuki A, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Masuda M, Ito K. PMID: 31865555.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    64. Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer. J Radiat Res. 2019 Nov 22; 60(6):831-836. Ishigaki T, Uruno T, Sugino K, Masaki C, Akaishi J, Hames KY, Suzuki A, Tomoda C, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Miyazaki S, Ito K. PMID: 31423531; PMCID: PMC6873619.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan. Thyroid. 2019 10; 29(10):1390-1398. Suzuki N, Noh JY, Hiruma M, Kawaguchi A, Morisaki M, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Iwaku K, Yoshihara A, Watanabe N, Sugino K, Ito K. PMID: 31573408.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    66. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma. World J Surg. 2019 09; 43(9):2235-2244. Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, Yabuta T, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Katoh R, Ito K. PMID: 31098668.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    67. The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma. Surgery. 2019 09; 166(3):342-348. Saito Y, Matsuzu K, Sugino K, Takami H, Kitagawa W, Nagahama M, Ito K. PMID: 31128851.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Sci Rep. 2019 04 01; 9(1):5404. Ozeki T, Nagahama M, Fujita K, Suzuki A, Sugino K, Ito K, Miura M. PMID: 30931962; PMCID: PMC6443943.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    69. Association of lenvatinib trough plasma concentrations with lenvatinib-induced toxicities in Japanese patients with thyroid cancer. Med Oncol. 2019 Mar 27; 36(5):39. Nagahama M, Ozeki T, Suzuki A, Sugino K, Niioka T, Ito K, Miura M. PMID: 30919115.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    70. Usefulness of Stereotactic Radiotherapy Using the CyberKnife for Patients with Inoperable Locoregional Recurrences of Differentiated Thyroid Cancer. World J Surg. 2019 Feb; 43(2):513-518. Ishigaki T, Uruno T, Tanaka T, Ogimi Y, Masaki C, Akaishi J, Hames KY, Yabuta T, Suzuki A, Tomoda C, Matsuzu K, Ohkuwa K, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 30267291.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Change of surgical strategy for Graves' disease from subtotal thyroidectomy to total thyroidectomy: a single institutional experience. Endocr J. 2019 Feb 28; 66(2):181-186. Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Uruno T, Matsuzu K, Suzuki A, Tomoda C, Y Hames K, Akaishi J, Masaki C, Ogimi Y, Yabuta T, Ito K. PMID: 30568070.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    72. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy. Thyroid. 2019 01; 29(1):128-134. Yoshihara A, Iwaku K, Noh JY, Watanabe N, Kunii Y, Ohye H, Suzuki M, Matsumoto M, Suzuki N, Tadokoro R, Sekiyama C, Hiruma M, Sugino K, Ito K. PMID: 30426886.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Clinical and Pathological Features of 30 Cases. World J Surg. 2018 11; 42(11):3616-3623. Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, Yabuta T, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Katoh R, Ito K. PMID: 29696324.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    74. Clinical Status and Treatment of Liver Metastasis of Differentiated Thyroid Cancer Using Tyrosine Kinase Inhibitors. World J Surg. 2018 11; 42(11):3632-3637. Saito Y, Sugino K, Takami H, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Kawakubo H, Ito K, Kitagawa Y. PMID: 29766229.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    75. Cohort study exploring the effect of lenvatinib on differentiated thyroid cancer. Endocr J. 2018 Nov 29; 65(11):1071-1074. Tahara M, Takami H, Ito Y, Sugino K, Takahashi S, Takeyama H, Tsutsui H, Hara H, Mitsuma A, Yamashita H, Okamoto T, Sugitani I, Ohashi Y, Imai T. PMID: 30369531.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    76. Rapid Growth and Early Metastasis of Papillary Thyroid Carcinoma in an Adolescent Girl with Graves' Disease. Horm Res Paediatr. 2019; 91(3):210-215. Shimura K, Shibata H, Mizuno Y, Amano N, Hoshino K, Kuroda T, Kameyama K, Matsuse M, Mitsutake N, Sugino K, Yoshimura Noh J, Hasegawa T, Ishii T. PMID: 30092570.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    77. Re: "High Thyroid Cancer Mortality Rate in Japan: A Result of Nonaggressive Treatment Strategy, or Just an Aging Population?" By Magner (Thyroid 2018;28:818-819). Thyroid. 2018 06; 28(6):820-822. Davies L, Sugino K, Sugitani I, Tomoda C. PMID: 29644937.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease. Clin Ophthalmol. 2018; 12:739-746. Suzuki N, Noh JY, Kameda T, Yoshihara A, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Iwaku K, Watanabe N, Mukasa K, Kozaki A, Inoue T, Sugino K, Ito K. PMID: 29719374; PMCID: PMC5914550.
      View in: PubMed   Mentions: 9  
    79. Seasonal Changes in Serum Thyrotropin Concentrations Observed from Big Data Obtained During Six Consecutive Years from 2010 to 2015 at a Single Hospital in Japan. Thyroid. 2018 04; 28(4):429-436. Yoshihara A, Noh JY, Watanabe N, Iwaku K, Kunii Y, Ohye H, Suzuki M, Matsumoto M, Suzuki N, Sugino K, Thienpont LM, Hishinuma A, Ito K. PMID: 29608438.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    80. Long-Term Outcomes of 107 Cases of Primary Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma at a Single Medical Institution in Japan. J Clin Endocrinol Metab. 2018 02 01; 103(2):732-739. Watanabe N, Narimatsu H, Noh JY, Iwaku K, Kunii Y, Suzuki N, Ohye H, Suzuki M, Matsumoto M, Yoshihara A, Kameyama K, Kobayashi K, Kami M, Sugino K, Ito K. PMID: 29165612.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    81. Globus Symptoms in Patients Undergoing Thyroidectomy: Relationships with Psychogenic Factors, Thyroid Disease, and Surgical Procedure. Thyroid. 2018 01; 28(1):104-109. Tomoda C, Sugino K, Tanaka T, Ogimi Y, Masaki C, Akaishi J, Hames KY, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 29183262.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    82. EZH2 Overexpression as a Useful Prognostic Marker for Aggressive Behaviour in Thyroid Cancer. In Vivo. 2018 Jan-Feb; 32(1):25-31. Masudo K, Suganuma N, Nakayama H, Oshima T, Rino Y, Iwasaki H, Matsuzu K, Sugino K, Ito K, Kondo T, Nakamura Y, Yoshihara M, Masuda M, Miyagi Y. PMID: 29275295; PMCID: PMC5892628.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    83. Clinical factors related to the efficacy of tyrosine kinase inhibitor therapy in radioactive iodine refractory recurrent differentiated thyroid cancer patients. Endocr J. 2018 Mar 28; 65(3):299-306. Sugino K, Nagahama M, Kitagawa W, Ohkuwa K, Uruno T, Matsuzu K, Suzuki A, Masaki C, Akaishi J, Hames KY, Tomoda C, Ogimi Y, Ito K. PMID: 29269689.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    84. Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma. Endocr J. 2017 Aug 30; 64(8):819-826. Masaki C, Sugino K, Saito N, Saito Y, Tanaka T, Ogimi Y, Maeda T, Osaku T, Akaishi J, Hames KY, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Takami H, Ito K. PMID: 28659544.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    85. A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH). Endocr J. 2017 Feb 27; 64(2):207-212. Kobayashi S, Yoshimura Noh J, Shimizu T, Sato T, Kurihara I, Sugino K, Itoh H, Ito K. PMID: 27904073.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    86. Outpatient 131I Treatment for a Patient with Graves' Disease Receiving Hemodialysis. Intern Med. 2016; 55(22):3309-3313. Suzuki M, Yoshimura Noh J, Sugino K, Ito K. PMID: 27853074; PMCID: PMC5173499.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    87. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years. Thyroid. 2016 12; 26(12):1706-1711. Tomoda C, Sugino K, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. PMID: 27616725.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    88. The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational study. Endocr J. 2016 Dec 30; 63(12):1113-1122. Yoshihara A, Yoshimura Noh J, Mukasa K, Watanabe N, Iwaku K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Endo K, Suzuki R, Hattori N, Sugino K, Ito K. PMID: 27600197.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    89. The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study. Thyroid. 2016 09; 26(9):1293-9. Onoda N, Sugino K, Higashiyama T, Kammori M, Toda K, Ito K, Yoshida A, Suganuma N, Nakashima N, Suzuki S, Tsukahara K, Noguchi H, Koizumi M, Nemoto T, Hara H, Miyauchi A, Sugitani I. PMID: 27484330.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    90. Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review]. Endocr J. 2016 Jul 30; 63(7):597-602. Ito Y, Suzuki S, Ito K, Imai T, Okamoto T, Kitano H, Sugitani I, Sugino K, Tsutsui H, Hara H, Yoshida A, Shimizu K. PMID: 27210070.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    91. Prognosis After Brain Metastasis from Differentiated Thyroid Carcinoma. World J Surg. 2016 Mar; 40(3):574-81. Saito F, Uruno T, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 26762631.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    92. Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: A report from the Anaplastic Thyroid Carcinoma Research Consortium of Japan. Endocr J. 2016 May 31; 63(5):441-7. Hirokawa M, Sugitani I, Kakudo K, Sakamoto A, Higashiyama T, Sugino K, Toda K, Ogasawara S, Yoshimoto S, Hasegawa Y, Imai T, Onoda N, Orita Y, Kammori M, Fujimori K, Yamada H. PMID: 26842589.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    93. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma. Endocr J. 2016; 63(3):257-61. Tomoda C, Ogimi Y, Saito F, Masaki C, Akaishi J, Matsuzu K, Suzuki A, Uruno T, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 26655349.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    94. Pathological Findings of the Thyroid Tissue in a Patient with Euthyroid Graves' Disease. Intern Med. 2015; 54(22):2881-4. Suzuki N, Yoshihara A, Yoshimura Noh J, Kozaki A, Inoue T, Sugino K, Ito K. PMID: 26568003.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    95. Inhibitory effect of low-dose inorganic iodine on thyroidal radioactive iodine uptake in healthy Japanese adults. Endocr J. 2016; 63(1):21-7. Kunii Y, Uruno T, Mukasa K, Sekiya K, Iwaku K, Suzuki A, Sugino K, Yoshimura Noh J, Ito K. PMID: 26560237.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    96. Papillary Thyroid Carcinoma in Children and Adolescents: Long-Term Follow-Up and Clinical Characteristics. World J Surg. 2015 Sep; 39(9):2259-65. Sugino K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Akaishi J, Masaki C, Matsuzu K, Ito K. PMID: 25802237.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    97. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. Thyroid. 2015 Oct; 25(10):1155-61. Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Kameda T, Iwaku K, Kobayashi S, Sugino K, Ito K. PMID: 26222916.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    98. Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma. World J Surg. 2015 Jul; 39(7):1728-35. Akaishi J, Sugino K, Kameyama K, Masaki C, Matsuzu K, Suzuki A, Uruno T, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Shimizu K, Ito K. PMID: 25743484.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    99. Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2). BMC Cancer. 2015 Jun 20; 15:475. Onoda N, Sugitani I, Higashiyama T, Hara H, Ito K, Kammori M, Sugino K, Suzuki S, Toda K, Yoshida A, Miyauchi A. PMID: 26091846; PMCID: PMC4474467.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    100. Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study. J Clin Endocrinol Metab. 2015 Jul; 100(7):2700-8. Watanabe N, Noh JY, Kozaki A, Iwaku K, Sekiya K, Kosuga Y, Matsumoto M, Suzuki M, Yoshihara A, Ohye H, Kobayashi S, Kunii Y, Mukasa K, Sugino K, Inoue T, Ito K. PMID: 25965082.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    101. Antimicrobial prophylaxis for the prevention of surgical site infection after thyroid and parathyroid surgery: a prospective randomized trial. World J Surg. 2015 May; 39(5):1282-7. Uruno T, Masaki C, Suzuki A, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 25566977.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    102. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT? Endocr J. 2015; 62(6):557-60. Yoshihara A, Noh JY, Mukasa K, Suzuki M, Ohye H, Matsumoto M, Kunii Y, Watanabe N, Suzuki N, Kameda T, Sugino K, Ito K. PMID: 25819223.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    103. Chemosensitivity of anaplastic thyroid cancer based on a histoculture drug response assay. Int J Endocrinol. 2015; 2015:967286. Uruno T, Masaki C, Akaishi J, Matsuzu K, Suzuki A, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 25866510; PMCID: PMC4381728.
      View in: PubMed   Mentions: 2  
    104. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. Thyroid. 2015 Jan; 25(1):43-50. Sato S, Noh JY, Sato S, Suzuki M, Yasuda S, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K, Nagataki S, Taniyama M. PMID: 25178068.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    105. Anaplastic thyroid carcinomas incidentally found on postoperative pathological examination. World J Surg. 2014 Sep; 38(9):2311-6. Yoshida A, Sugino K, Sugitani I, Miyauchi A. PMID: 24687351.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    106. Changes in pediatric thyroid sonograms in or nearby the Kanto region before and after the accident at the Fukushima Daiichi nuclear power plant. Endocr J. 2014; 61(9):875-81. Iwaku K, Noh JY, Sasaki E, Suzuki N, Kameda T, Kobayashi S, Yoshihara A, Ohye H, Watanabe N, Suzuki M, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K. PMID: 25008050.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    107. Development of molecular targeted drugs for advanced thyroid cancer in Japan. Endocr J. 2014; 61(9):833-9. Takami H, Ito K, Sugino K. PMID: 24849385.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    108. Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients. Thyroid. 2014 Jun; 24(6):994-9. Watanabe N, Narimatsu H, Noh JY, Kunii Y, Mukasa K, Matsumoto M, Suzuki M, Sekiya K, Ohye H, Yoshihara A, Iwaku K, Kobayashi S, Kobayashi S, Kameyama K, Kobayashi K, Nishikawa Y, Kami M, Sugino K, Ito K. PMID: 24547778; PMCID: PMC4046220.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    109. Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid? Ann Surg Oncol. 2014 Sep; 21(9):2981-6. Sugino K, Kameyama K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Akaishi J, Suzuki A, Masaki C, Matsuzu K, Kawano M, Ito K. PMID: 24770681.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    110. Optimal timing of surgery for differentiated thyroid cancer in pregnant women. World J Surg. 2014 Mar; 38(3):704-8. Uruno T, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. PMID: 24248429.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    111. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment. Thyroid. 2014 May; 24(5):796-801. Kobayashi S, Noh JY, Mukasa K, Kunii Y, Watanabe N, Matsumoto M, Ohye H, Suzuki M, Yoshihara A, Iwaku K, Sugino K, Ito K. PMID: 24341564.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    112. Follicular thyroid carcinoma with distant metastasis: outcome and prognostic factor. Endocr J. 2014; 61(3):273-9. Sugino K, Kameyama K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Akaishi J, Suzuki A, Masaki C, Matsuzu K, Kawano M, Ito K. PMID: 24420337.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    113. Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy. J Thyroid Res. 2014; 2014:952352. Yoshihara A, Noh JY, Watanabe N, Iwaku K, Kobayashi S, Suzuki M, Ohye H, Matsumoto M, Kunii Y, Mukasa K, Sugino K, Ito K. PMID: 24523983; PMCID: PMC3913092.
      View in: PubMed   Mentions: 5  
    114. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg. 2014 Jan; 38(1):68-79. Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K. PMID: 24081532.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    115. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma? Ann Surg Oncol. 2013 Sep; 20(9):2944-50. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K. PMID: 23616135.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    116. Diagnostic accuracy of fine needle aspiration biopsy cytology and ultrasonography in patients with thyroid nodules diagnosed as benign or indeterminate before thyroidectomy. Endocr J. 2013; 60(3):375-82. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K. PMID: 23197046.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    117. Serum intact parathyroid hormone level after total thyroidectomy or total thyroidectomy plus lymph node dissection for thyroid nodules: report from 296 surgical cases. Int J Endocrinol Metab. 2012; 10(4):594-8. Yano Y, Masaki C, Sugino K, Nagahama M, Kitagawa W, Sibuya H, Ito K. PMID: 23843829; PMCID: PMC3693643.
      View in: PubMed   Mentions: 5  
    118. Changes in the thyroid function of Graves' disease patients treated by subtotal thyroidectomy. Endocr J. 2012; 59(12):1115-20. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K. PMID: 22971989.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    119. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid. 2012 Aug; 22(8):798-804. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K. PMID: 22853727.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    120. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg. 2012 Jun; 36(6):1247-54. Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S. PMID: 22311136.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    121. Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy. Ann Nucl Med. 2011 Dec; 25(10):749-54. Yano Y, Sugino K, Akaishi J, Uruno T, Okuwa K, Shibuya H, Kitagawa W, Nagahama M, Ito K, Ito K. PMID: 21971604.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    122. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid. 2011 Nov; 21(11):1183-9. Akaishi J, Sugino K, Kitagawa W, Nagahama M, Kameyama K, Shimizu K, Ito K, Ito K. PMID: 21936674.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    123. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid. 2011 Jul; 21(7):751-7. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Kameyama K, Ito K. PMID: 21615311.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    124. Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring. Endocr J. 2010; 57(11):953-8. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Ito K. PMID: 20823623.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    125. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol. 2009 Dec; 16(12):3442-9. Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Nakayama H, Hirakawa S, Yukawa N, Rino Y, Masuda M, Ito K. PMID: 19777194.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    126. Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival. BMC Cancer. 2009 Sep 01; 9:306. Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Nakayama H, Hirakawa S, Rino Y, Masuda M, Ito K. PMID: 19723317; PMCID: PMC2746228.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    127. Long-term changes in parathyroid function after subtotal thyroidectomy for graves' disease. World J Surg. 2008 Dec; 32(12):2612-6. Yano Y, Nagahama M, Sugino K, Ito K, Ito K. PMID: 18836764.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    128. Endoscopic tumor ablation for laryngotracheal intraluminal invasion secondary to advanced thyroid cancer. Acta Otolaryngol. 2008 Jul; 128(7):799-807. Tsutsui H, Usuda J, Kubota M, Yamada M, Suzuki A, Shibuya H, Miyajima K, Tanaka K, Sugino K, Ito K, Kato H. PMID: 18568524.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    129. Airway stenting for the treatment of laryngotracheal stenosis secondary to thyroid cancer. Respirology. 2008 Sep; 13(5):632-8. Tsutsui H, Kubota M, Yamada M, Suzuki A, Usuda J, Shibuya H, Miyajima K, Sugino K, Ito K, Furukawa K, Kato H. PMID: 18513246.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    130. Surgical management of Graves' disease -10-year prospective trial at a single institution. Endocr J. 2008 Mar; 55(1):161-7. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ito K. PMID: 18250542.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    131. Recent outcome of Graves' disease patients with papillary thyroid cancer. Eur J Endocrinol. 2007 Sep; 157(3):325-9. Yano Y, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K, Ito K. PMID: 17766715.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    132. Paraganglioma of the thyroid: report of a male case with ultrasonographic imagings, cytologic, histologic, and immunohistochemical features. Thyroid. 2007 Jun; 17(6):575-8. Yano Y, Nagahama M, Sugino K, Ito K, Kameyama K, Ito K. PMID: 17614779.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    133. Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH. Endocr J. 2006 Dec; 53(6):723-8. Sugino K, Ito K, Takami H. PMID: 16960401.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    134. Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation. Oncol Rep. 2006 Jul; 16(1):123-6. Kumagai A, Namba H, Mitsutake N, Saenko VA, Ohtsuru A, Ito M, Noh JY, Sugino K, Ito K, Yamashita S. PMID: 16786134.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    135. [Anaplastic carcinoma of the thyroid]. Nihon Rinsho. 2006 May 28; Suppl 1:485-8. Sugino K, Ito K. PMID: 16776196.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    136. [Metastatic tumors of the thyroid]. Nihon Rinsho. 2006 May 28; Suppl 1:497-9. Sugino K, Ito K. PMID: 16776199.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    137. A cavernous haemangioma of the thyroid gland. J Laryngol Otol. 2005 Oct; 119(10):828-30. Kano M, Kameyama K, Hosoda Y, Sugino K, Ito K. PMID: 16259665.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    138. Clinical evaluation of color Doppler imaging for the differential diagnosis of thyroid follicular lesions. World J Surg. 2004 Dec; 28(12):1261-5. Fukunari N, Nagahama M, Sugino K, Mimura T, Ito K, Ito K. PMID: 15517496.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    139. Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab. 2004 Sep; 89(9):4280-4. Kumagai A, Namba H, Saenko VA, Ashizawa K, Ohtsuru A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S, Thomas GA, Bogdanova TI, Tronko MD, Nagayasu T, Shibata Y, Yamashita S. PMID: 15356022.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    140. Surgical treatment of Graves' disease in children. Thyroid. 2004 Jun; 14(6):447-52. Sugino K, Ito K, Mimura T, Fukunari N, Nagahama M, Ito K. PMID: 15242572.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    141. Composite metastatic carcinoma in lymph nodes of patients with concurrent medullary and papillary thyroid carcinoma: a report of two cases. Endocr Pathol. 2004; 15(1):83-8. Seki T, Kameyama K, Hayashi H, Nagahama M, Masudo K, Fukunari N, Tanaka K, Sugino K, Ito K, Takami H. PMID: 15067180.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    142. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003 Mar; 237(3):399-407. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y. PMID: 12616125; PMCID: PMC1514312.
      View in: PubMed   Mentions: 294     Fields:    Translation:Humans
    143. Hyperthyroidism and the management of atrial fibrillation. Thyroid. 2002 Jun; 12(6):489-93. Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. PMID: 12165111.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    144. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery. 2002 Mar; 131(3):245-8. Sugino K, Ito K, Mimura T, Nagahama M, Fukunari N, Kubo A, Iwasaki H, Ito K. PMID: 11894027.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    Kim's Networks
    Concepts (313)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California